19 August 2019
Everyone who works in child health has a responsibility to safeguard and protect children from violence, exploitation and abuse. RCPCH members can access a number of resources to support this work.
13 August 2019
Last week, NICE published draft recommendations on the use of cannabis-based medicinal products (CBMPs) following evaluation of their clinical and cost-effectiveness, and NHS England published a review aimed at assessing the barriers to prescribing cannabis-based medicinal products where it is safe ...
10 May 2019
Our first version is now ready for stress testing by a select group of parents and families from our charity partner, WellChild. If you're joining us at RCPCH Conference and exhibition on 13-15 May, come to our stand for a sneak preview!
29 March 2019
Experts from 13 national bodies, including seven Royal Colleges, have joined forces to launch new practical guidance to support doctors and other health professionals around valproate use in women and girls in their reproductive years.
25 March 2019
Wales has taken the next step towards protecting children’s’ rights by introducing legislation to end the physical punishment of children. RCPCH responds.
1 February 2019
We have worked with NHS England on a programme to ensure children and young people with a learning disability, autism or both are able to access appropriate medication, and are not prescribed inappropriate psychotropic medication. Find out more and read our full pledge.
6 December 2018
A new feature for our 2019 RCPCH Conference and exhibition, these talks will showcase the latest ideas and discoveries in child health.
30 October 2018
RCPCH responds to new research which suggests these drugs may alter gut microbes associated with weight gain.
23 October 2018
As the Chancellor's budget approaches, over 100 organisations, including the RCPCH, come together to ask that he puts children at the heart of its spending decisions.
1 October 2018
The Department of Health & Social Care has issued urgent guidance relating to supply disruption of Mylan EpiPens for all health care professionals who prescribe, dispense or administer adrenaline auto-injectors.